Vineet Laboratories Share Price Today

Vineet Laboratories gets 2-month AGM extension to November 30

Vineet Laboratories received a two-month AGM extension from ROC Hyderabad. New deadline for the 10th AGM is set for November 30, 2026. Extension granted under Section 96(1) of the Companies Act, 2013. Board to fix final date and release annual report for FY25 shortly.

Vineet Laboratories Q4FY26 Results: Net profit turns positive at ₹72.5 lakh

Net profit for Q4FY26 was ₹72.51 lakh, reversing a loss of ₹1,052.51 lakh in Q4FY25. Full year net profit stood at ₹111.08 lakh against a loss of ₹2,019.10 lakh in FY25. Revenue from operations for Q4FY26 rose to ₹1,889.14 lakh from ₹1,407.65 lakh YoY. Other expenses dropped significantly to ₹821.77 lakh in FY26 from ₹1,570.39 lakh in FY25. Outstanding long-term borrowings reduced to ₹35.29 crore from ₹39.09 crore.

Vineet Labs MD Gaddam Venkata Ramana steps down on July 21, 2026

Gaddam Venkata Ramana ceased to be the Managing Director of Vineet Laboratories Limited on July 21, 2026, while continuing as a Non-Executive Director. The regulatory filing confirmed he is not debarred from holding the director's office and holds 4,71,000 equity shares.

Vineet Labs appoints Rajesh Kumar Kathulla as Executive Director

Vineet Laboratories Limited has appointed Mr. Rajesh Kumar Kathulla as an Additional Director (Executive) for a five-year term starting June 11, 2026, pending shareholder approval. The Board approved the appointment to leverage his experience in renewable energy and organic agriculture. Mr. Kathulla holds 50,254 equity shares and is not related to existing directors or promoters.

Vineet Laboratories defers board meeting to approve FY26 results

Vineet Laboratories Limited has deferred its board meeting originally scheduled for July 15, 2026, due to unavoidable circumstances. The meeting was intended to consider and approve the audited financial results for the financial year ended March 31, 2026. A fresh notice specifying the revised date, time, and venue will be intimated to the exchanges in due course.

Vineet Laboratories confirms no encumbrance of shares in FY26

Vineet Laboratories disclosed that its promoters have not created any encumbrance on shares during FY26. The declaration, submitted by promoter A Srinivasa Raju, covers 11,49,097 equity shares held along with Persons Acting in Concert (PACs). This filing complies with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.